Global Market: Japan’s Nikkei plunges nearly 5% as AI stocks tumble on CoreWeave debt concerns

Japan’s Nikkei share average plunged nearly 5% on Thursday, with artificial intelligence-linked stocks leading the selloff amid concerns over the financial health of US cloud-computing provider CoreWeave and fears of higher interest rates following hotter-than-expected US inflation data, Reuters reported.

The tech-heavy Nikkei 225 fell 4.8% to 64,489.06 at the midday recess, while the broader Topix declined 2.5%, Reuters reported.

Read more: South Korea triggers 'sidecar' trading halt, KOSPI slumps over 7%


AI-related stocks bore the brunt of the selling, with chip equipment makers Advantest and Tokyo Electron tumbling 13.9% and 7.3%, respectively. SoftBank Group, a major investor in AI-focused startups, dropped 9.4%.

The selloff followed stronger-than-expected US consumer price inflation data, which fuelled expectations that the Federal Reserve could raise interest rates sooner than anticipated and keep borrowing costs elevated for longer. Higher interest rates typically weigh on technology companies, particularly those that rely heavily on debt to finance expansion.

On Wednesday, the US Nasdaq Composite fell 1.9% as investors reassessed the outlook for interest rates and the valuations of technology stocks.

Read more: Global Market Today: Stock selloff extends to Asia as chip rout deepens

Concerns surrounding CoreWeave added to the pressure on AI-linked shares. The company's stock plunged more than 15% despite its chief executive's assurances in an employee memo that its substantial deal backlog was sufficient to cover its debt obligations, Reuters reported.

The developments have also heightened concerns about the sustainability of AI-related capital expenditure and the ability of companies to generate adequate returns on their investments.

According to Reuters, Nomura strategist Wataru Akiyama said concerns about the financial health of AI-related companies had intensified, prompting investors to question the outlook for AI capital spending and the profitability of AI businesses.

The weakness in technology stocks contrasted with gains in defensive sectors. Pharmaceuticals emerged as the Tokyo exchange's best-performing industry group, rising 3.4% as investors shifted towards companies considered relatively resilient during periods of market volatility.

Sumitomo Pharma was the biggest percentage gainer among Nikkei 225 constituents, advancing 13%.

Market breadth remained negative, with 145 stocks declining and 80 advancing among the Nikkei's 225 constituents at the midday break, underscoring the extent of the selloff.

(Disclaimer: This article is based on inputs from agencies. These do not represent the views of The Economic Times)